Jump to content

Talk:Giant-cell tumor of the tendon sheath

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia

Article categorization

[edit]

This article was categorized based on scheme outlined at WP:DERM:CAT. kilbad (talk) 16:45, 27 December 2008 (UTC)[reply]

Edit Request

[edit]

NOTE: I am proposing this edit for FleishmanHillard on behalf of Daiichi Sankyo. I am a paid editor and am aware of the COI guidelines.

I am submitting this edit request to bring your attention to the fact that the World Health Organization reclassified pigmented villonodular synovitis (PVNS) and giant-cell tumor of the tendon sheath (GCT-TS) to “tenosynovial giant cell tumor” or “TGCT” in 2013 in its 4th edition of WHO Classification of Tumours of Soft Tissue and Bone [1] (paid subscription required) to encompass a family of lesions in the soft tissue surrounding large & small joints, which all share a common pathogenesis.

As you know, this is a rare disease with very limited online resources, and the scientific and medical community are continually learning more about the condition. There are several resources containing information about TGCT, and a few are provided below, which should not be considered all-inclusive. Publications about TGCT have been posted by:

  • National Institutes of Health (The Patient Perspective on the Impact of Tenosynovial Giant Cell Tumors on Daily Living: Crowdsourcing Study on Physical Function and Quality of Life [2]; Localized and diffuse forms of tenosynovial giant cell tumor (formerly giant cell tumor of the tendon sheath and pigmented villonodular synovitis) [3].
  • Clinicaltrials.gov, where you can see that TGCT trials [4] include both PVNS trials [5] and giant cell tumor of the tendon sheath trials [6].

We gather it is your objective to ensure the community has as much accurate and up-to-date information possible. Toward that end, we’re requesting that the existing GCT-TS page be updated to include “TGCT” as an overarching name for the condition as adopted by the World Health Organization and the National Organization for Rare Disorders.

Thank you for your consideration. Jon Gray (talk) 22:55, 31 October 2018 (UTC)[reply]

References

  1. ^ Fletcher, C. D.M.; Bridge, J.A.; Hogendoorn, P.; Mertens, F. (2013). WHO Classification of Tumours of Soft Tissue and Bone. Fourth Edition. World Health Organization. p. 100-103. ISBN 9789283224341.
  2. ^ Monique Josephine Mastboom, MD, Rosa Planje, BSc and Michiel Adreanus van de Sande, MD (February 23, 2018). "The Patient Perspective on the Impact of Tenosynovial Giant Cell Tumors on Daily Living: Crowdsourcing Study on Physical Function and Quality of Life". National Institutes of Health. Retrieved October 24, 2018. Tenosynovial giant cell tumor (TGCT), previously pigmented villonodular synovitis (PVNS), is a rare, proliferative neoplasm affecting the synovial lining of joints, bursae, and tendons sheaths. {{cite journal}}: Cite journal requires |journal= (help)CS1 maint: multiple names: authors list (link)
  3. ^ Gouin F., Noailles, T. (February 2017). "Localized and diffuse forms of tenosynovial giant cell tumor (formerly giant cell tumor of the tendon sheath and pigmented villonodular synovitis)". National Institutes of Health. Retrieved October 24, 2018. {{cite journal}}: Cite journal requires |journal= (help)CS1 maint: multiple names: authors list (link)
  4. ^ . Clinicaltrials.gov https://clinicaltrials.gov/ct2/results?cond=&term=tenosynovial+giant+cell+tumor&cntry=&state=&city=&dist. Retrieved October 24, 2018. {{cite web}}: Missing or empty |title= (help)
  5. ^ . Clinicaltrials.gov https://clinicaltrials.gov/ct2/results?cond=&term=pigmented+villonodular+synovitis&cntry=&state=&city=&dist=. Retrieved October 24, 2018. {{cite web}}: Missing or empty |title= (help)
  6. ^ . Clinicaltrials.gov https://clinicaltrials.gov/ct2/results?cond=giant+cell+tumor+of+the+tendon+sheath&term=&cntry=&state=&city=&dist. Retrieved October 24, 2018. {{cite web}}: Missing or empty |title= (help)

Reply 01-NOV-2018

[edit]

  Clarification requested  

  1. If your request is to change the article's title, those requests should be submitted using {{requested move}} specifically as a controversial move request process requiring discussion amongst the wider community. More information may be found at requested moves.
  2. If your request is to change the instance of the word in certain areas of the article, please propose verbatim the changes here on the talk page.

If choice number two above is your intention, kindly change the {{request edit}} template's answer parameter to read from |ans=yes to |ans=no
Regards,  Spintendo  07:56, 1 November 2018 (UTC)[reply]

Clarification on Edit Request

[edit]

NOTE: I am proposing this edit for FleishmanHillard on behalf of Daiichi Sankyo. I am a paid editor and am aware of the COI guidelines.

@Spintendo: As a follow up to your request for clarification, our request is submitted with the intention of adding a passage to the existing first sentence of the page which introduces localized tenosynovial giant cell tumor as an alternate name for giant-cell tumor of the tendon sheath. Requested verbatim addition (bolded) and sourcing follow:

  • Giant-cell tumor of the tendon sheath, also known as giant-cell synovioma, localized nodular tenosynovitis and localized tenosynovial giant cell tumor or TGCT[1] is a firm lesion, measuring 1 to 3 cm in diameter, and is most commonly attached to the tendons of the fingers, hands, and wrists, with a predilection for the flexor surfaces.

Also, as giant-cell tumor of the tendon sheath and pigmented villonodular synovitis are related conditions, we also would like to request that the “See also” section of this page be updated to include a link to the pigmented villonodular synovitis Wikipedia page. The “See also” section of pigmented villonodular synovitis page has a link to the giant-cell tumor of the tendon sheath Wikipedia page, so we’re hoping to add a cross-link here so people who are learning about the related conditions can quickly access additional information about each disease. Thank you for your consideration. Jon Gray (talk) 16:06, 6 December 2018 (UTC)[reply]

References

  1. ^ Fletcher, C. D.M.; Bridge, J.A.; Hogendoorn, P.; Mertens, F. (2013). WHO Classification of Tumours of Soft Tissue and Bone. Fourth Edition. World Health Organization. p. 100. ISBN 9789283224341. This family of lesions includes the localized giant cell tumour of tendon sheath/tenosynovial giant cell tumour, and the more diffuse and destructive variant called diffuse-type giant cell tumour/pigmented villonodular synovitis.

Reply 06-DEC-2018

[edit]

  Edit request declined  

Regards,  Spintendo  02:02, 7 December 2018 (UTC)[reply]

References

  1. ^ "MOS:LEADLINK". Wikipedia. 20 November 2018.